Nevertheless, elevated levels of SCAND2 RNA are novel potential markers of better prognoses in several cancer types, including pancreatic cancer, head and neck cancers, lung adenocarcinoma, sarcoma, and cervical cancer. This evidence concerns the gene SCAND2P and head and neck cancer.